MLchartDataset catalogue

Evoxac

Term · Oncology and biomedicine · MLC-T-ONC-003041

A drug used to treat certain disorders of the salivary gland. It is also being studied as a treatment for dry mouth caused by radiation therapy to the head and neck. It increases the amount of saliva and sweat made by saliva and sweat glands. Evoxac is a type of cholinergic agonist. Also called cevimeline hydrochloride.

Table 1. Record
IdentifierMLC-T-ONC-003041
FieldOncology and biomedicine
Synonymscevimeline hydrochloride
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003041",
  "term": "Evoxac",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat certain disorders of the salivary gland. It is also being studied as a treatment for dry mouth caused by radiation therapy to the head and neck. It increases the amount of saliva and sweat made by saliva and sweat glands. Evoxac is a type of cholinergic agonist. Also called cevimeline hydrochloride.",
  "synonyms": [
    "cevimeline hydrochloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/evoxac/"
}

Record 7,009 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.